Head-to-head · WeighScore
NexLife vs Rewinding RX
The verdict
NexLife takes it — 68.5/100 to 59.5/100.
NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NexLife | Rewinding RX |
|---|---|---|
| WeighScore | 68.5/100 | 59.5/100 |
| Grade | C | C |
| Scorecard rank | #149 | #340 |
| Semaglutide | $165/mo (compounded) | Not disclosed |
| Tirzepatide | $215/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #149 · C
Strengths
- LegitScript certified platform
- Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
- Both semaglutide and tirzepatide at competitive pricing
- Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset
Where it loses points
- State availability not publicly disclosed
- Compounded only — no brand-name options
- Also covers hormone optimization and longevity
- Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
Graded #340 · C
Strengths
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer — uncommon transparency
- MD-only physician network ('never a physician assistant or nurse')
- All-50-state coverage with physician state-licensing matching
- Corporate entity disclosed (Rewinding RX Ltd.)
Where it loses points
- Pricing not shown — fully gated behind sign-up
- Pharmacy partner not named (only generic 503A/503B references)
- Medical director / clinical leadership not disclosed
- Governing law, arbitration venue, and corporate address not disclosed
- Tirzepatide not listed on the homepage (semaglutide only confirmed)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.